AstraZeneca AG

AstraZeneca in Switzerland AstraZeneca is a global, science-led biopharmaceutical company that has been present in Switzerland for nearly 50 years, ranking among the country's top ten revenue-generating pharmaceutical firms. AstraZeneca focuses on the discovery, development, and commercialisation of prescription medicines in the areas of Oncology, Cardiovascular, Renal and Metabolism, Respiratory and Immunology, and Rare Diseases. Over 285 employees in Switzerland are committed to providing patients with life-changing medicines and making a positive impact on the healthcare system, society, and the planet. Currently, over 230,000 people are treated with a drug from AstraZeneca in Switzerland. By 2026, the company expects the approval of over 35 new therapies. AstraZeneca has pledged to an inclusive work environment based on respect and acceptance. The company was thus recognised as a «Great Place to Work» for the sixth consecutive time in 2024 and carries the «Swiss LGBTI label». AstraZeneca aims to be CO2-negative by 2030.